Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
High
New patients with pulmonary TB should receive a regimen containing 6 months of rifampicin: 2HRZE/4HR
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Treatment of Tuberculosis: Guidelines
Year2010
Institution
Guideline
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Year2017
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWorld Health Organization